The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $78.39

Today's change+2.39 +3.14%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $78.39

Today's change+2.39 +3.14%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

AmSurg Corp up sharply

AmSurg Corp closed up sharply Wednesday, rallying (U.S.)$2.39 or 3.14% to (U.S.)$78.39. Shares have lost 0.81% over the last five days, but have gained 43.23% over the last year to date. This security has outperformed the S&P 500 by 47.97% during the last year.

Key company metrics

  • Open(U.S.) $77.01
  • Previous close(U.S.) $76.00
  • High(U.S.) $78.50
  • Low(U.S.) $76.12
  • Bid / Ask(U.S.) $74.34 / (U.S.) $82.41
  • YTD % change+43.23%
  • Volume372,219
  • Average volume (10-day)502,334
  • Average volume (1-month)529,021
  • Average volume (3-month)381,506
  • 52-week range(U.S.) $47.68 to (U.S.) $87.21
  • Beta0.99
  • Trailing P/E58.17×
  • P/E 1 year forward21.40×
  • Forward PEG1.08×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.35
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.10%

Based on its net profit margin of 12.10%, AmSurg Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue642570579503
Total other revenue--------
Total revenue642570579503
Gross profit596528536461
Total cost of revenue46434342
Total operating expense496457448408
Selling / general / administrative322304293266
Research & development--------
Depreciation / amortization24232321
Interest expense (income), net operating--------
Unusual expense (income)3000
Other operating expenses, total105919382
Operating income14611313295
Interest income (expense), net non-operating-30-30-30-39
Gain (loss) on sale of assets--------
Other--------
Income before tax1168310139
Income after tax91697939
Income tax, total2514220
Net income342127-10
Total adjustments to net income-2-2-2-2
Net income before extra. items342127-8
Minority interest-57-48-52-47
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items311925-10
Inc. avail. to common incl. extra. items311925-12
Diluted net income311925-12
Dilution adjustment----00
Diluted weighted average shares48484746
Diluted EPS excluding extraordinary itemsvalue per share0.650.390.53-0.22
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.700.400.53-0.22